Manila Times Business
Intravacc and SynphaBase Announce Strategic Partnership to Advance Conjugate Vaccine Development
The companies will combine their complementary expertise in synthetic oligosaccharides, conjugation process development and GMP vaccine manufacturing to support partners developing next-generation conjugate vaccines SynphaBase brings deep expertise in glycochemistry and the application, production, supply and regulatory support of synthetic oligosaccharides for conjugate vaccine developmentIntravacc contributes proven capabilities in conjugation process development, scale-up and GMP production o
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Twenty-six years later: Finally seeing the first sunrise at Pusan Point
Just now
BSB Junrose strengthens portfolio for hybrid, EV, and conventional vehicles
Just now
FAW trucks launches 'Wheels of Hope' outreach for Rizal school
Just now
100x Leverage, No KYC, $50 Welcome Bonus, and Double Deposit Bonus - Trade Crypto Futures on BexBack
Just now